157 related articles for article (PubMed ID: 12618275)
1. Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates.
Waddington EI; Croft KD; Sienuarine K; Latham B; Puddey IB
Atherosclerosis; 2003 Mar; 167(1):111-20. PubMed ID: 12618275
[TBL] [Abstract][Full Text] [Related]
2. Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography.
Waddington E; Sienuarine K; Puddey I; Croft K
Anal Biochem; 2001 May; 292(2):234-44. PubMed ID: 11355856
[TBL] [Abstract][Full Text] [Related]
3. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease.
Shishehbor MH; Zhang R; Medina H; Brennan ML; Brennan DM; Ellis SG; Topol EJ; Hazen SL
Free Radic Biol Med; 2006 Dec; 41(11):1678-83. PubMed ID: 17145556
[TBL] [Abstract][Full Text] [Related]
4. Similarity in the distribution of F(2)-isoprostanes in the lipid subfractions of atherosclerotic plaque and in vitro oxidised low density lipoprotein.
Waddington EI; Puddey IB; Mori TA; Croft KD
Redox Rep; 2002; 7(3):179-84. PubMed ID: 12189049
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.
Gniwotta C; Morrow JD; Roberts LJ; Kühn H
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3236-41. PubMed ID: 9409317
[TBL] [Abstract][Full Text] [Related]
6. Analysis of monohydroxyeicosatetraenoic acids and F2-isoprostanes as markers of lipid peroxidation in rat brain mitochondria.
Wiswedel I; Hirsch D; Nourooz-Zadeh J; Flechsig A; Lück-Lambrecht A; Augustin W
Free Radic Res; 2002 Jan; 36(1):1-11. PubMed ID: 11999696
[TBL] [Abstract][Full Text] [Related]
7. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis.
Mallat Z; Nakamura T; Ohan J; Lesèche G; Tedgui A; Maclouf J; Murphy RC
J Clin Invest; 1999 Feb; 103(3):421-7. PubMed ID: 9927504
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism.
Zein CO; Lopez R; Fu X; Kirwan JP; Yerian LM; McCullough AJ; Hazen SL; Feldstein AE
Hepatology; 2012 Oct; 56(4):1291-9. PubMed ID: 22505276
[TBL] [Abstract][Full Text] [Related]
9. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids.
Vigor C; Bertrand-Michel J; Pinot E; Oger C; Vercauteren J; Le Faouder P; Galano JM; Lee JC; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():65-78. PubMed ID: 24856297
[TBL] [Abstract][Full Text] [Related]
10. alpha-Hydroxyaldehydes, products of lipid peroxidation.
Loidl-Stahlhofen A; Spiteller G
Biochim Biophys Acta; 1994 Mar; 1211(2):156-60. PubMed ID: 8117742
[TBL] [Abstract][Full Text] [Related]
11. Profiling of oxidized lipid products of marine fish under acute oxidative stress.
Chung ML; Lee KY; Lee CY
Food Chem Toxicol; 2013 Mar; 53():205-13. PubMed ID: 23220612
[TBL] [Abstract][Full Text] [Related]
12. Exchange of unsaturated fatty acids between adipose tissue and atherosclerotic plaque studied with artificial neural networks.
Stachowska E; Gutowska I; Dołegowska B; Chlubek D; Bober J; Rać M; Gutowski P; Szumilowicz H; Turowski R
Prostaglandins Leukot Essent Fatty Acids; 2004 Jan; 70(1):59-66. PubMed ID: 14643180
[TBL] [Abstract][Full Text] [Related]
13. [The content of copper and zinc in human ulcerated carotid plaque].
Radak D; Cvetković Z; Tasić N; Petrović B; Lacković V; Djordjević-Denić G
Srp Arh Celok Lek; 2004; 132(3-4):80-4. PubMed ID: 15307308
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feldstein AE; Lopez R; Tamimi TA; Yerian L; Chung YM; Berk M; Zhang R; McIntyre TM; Hazen SL
J Lipid Res; 2010 Oct; 51(10):3046-54. PubMed ID: 20631297
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events.
Peeters W; de Kleijn DP; Vink A; van de Weg S; Schoneveld AH; Sze SK; van der Spek PJ; de Vries JP; Moll FL; Pasterkamp G
Eur Heart J; 2011 Jul; 32(14):1758-68. PubMed ID: 21059735
[TBL] [Abstract][Full Text] [Related]
16. GC-MS Analysis of Lipid Oxidation Products in Blood, Urine, and Tissue Samples.
Barden A; Mori TA
Methods Mol Biol; 2018; 1730():283-292. PubMed ID: 29363082
[TBL] [Abstract][Full Text] [Related]
17. Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.
Ravandi A; Babaei S; Leung R; Monge JC; Hoppe G; Hoff H; Kamido H; Kuksis A
Lipids; 2004 Feb; 39(2):97-109. PubMed ID: 15134136
[TBL] [Abstract][Full Text] [Related]
18. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.
Thies F; Garry JM; Yaqoob P; Rerkasem K; Williams J; Shearman CP; Gallagher PJ; Calder PC; Grimble RF
Lancet; 2003 Feb; 361(9356):477-85. PubMed ID: 12583947
[TBL] [Abstract][Full Text] [Related]
19. Human tear lipocalin acts as an oxidative-stress-induced scavenger of potentially harmful lipid peroxidation products in a cell culture system.
Lechner M; Wojnar P; Redl B
Biochem J; 2001 May; 356(Pt 1):129-35. PubMed ID: 11336644
[TBL] [Abstract][Full Text] [Related]
20. Reactive aldehyde-scavenging enzyme activities in atherosclerotic plaques of cigarette smokers and nonsmokers.
Lapenna D; Ciofani G; Ucchino S; Giamberardino MA; Di Ilio C; Cuccurullo F
Atherosclerosis; 2015 Feb; 238(2):190-4. PubMed ID: 25528427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
